Understanding RNAi
RNA interference (RNAi) is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?

Learn about RNAi and our investigational therapies
Read More ›
Alnylam is focused on 4 Strategic Therapeutic Areas (STArs): genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases

Alnylam is dedicated to providing support for affected individuals, families, and caregivers

Interested in our clinical trials?
Our Focus On You
A Family Living with
Primary Hyperoxaluria Type 1 (PH1)
Get more information about primary hyperoxaluria.
SIGN UP FOR EMAIL UPDATES
SIGN UP FOR EMAIL UPDATES
Receive news and updates on the work at Alnylam that affects you most.